Free Trial

GoviEx Uranium (CVE:GXU) Stock Price Up 27.8% - Still a Buy?

GoviEx Uranium logo with Energy background

Key Points

  • GoviEx Uranium Inc. (CVE:GXU) experienced a significant stock price increase of 27.8% during mid-day trading, reaching C$0.12 after previously closing at C$0.09.
  • The company's trading volume surged to approximately 67.8 million shares, a remarkable 4,190% increase from its average daily volume of 1.6 million shares.
  • GoviEx Uranium focuses on uranium property acquisition, exploration, and development in Africa, with key assets including the Madaouela project in Niger and the Muntanga project in Zambia.
  • Five stocks to consider instead of GoviEx Uranium.

GoviEx Uranium Inc. (CVE:GXU - Get Free Report)'s stock price rose 27.8% during trading on Wednesday . The stock traded as high as C$0.12 and last traded at C$0.12. Approximately 67,820,589 shares traded hands during trading, an increase of 4,190% from the average daily volume of 1,581,049 shares. The stock had previously closed at C$0.09.

GoviEx Uranium Stock Performance

The company has a market capitalization of C$117.54 million, a P/E ratio of -11.50 and a beta of 1.82. The firm's fifty day moving average is C$0.06 and its 200 day moving average is C$0.06.

About GoviEx Uranium

(Get Free Report)

GoviEx Uranium Inc, a mineral resources company, engages in the acquisition, exploration, and development of uranium properties in Africa. The company's principal asset is the Madaouela project which holds 80% interest located in north-central Niger. It also owns 100% interest in the Muntanga project that consists of 3 mining licenses situated to the south of Lusaka, Zambia; and the Falea project, which consists of three exploration licenses located in Mali.

Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in GoviEx Uranium Right Now?

Before you consider GoviEx Uranium, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and GoviEx Uranium wasn't on the list.

While GoviEx Uranium currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.